Latest News
I love writing guest articles and collaborating
See appearances for Asa's events and podcasts
Sep 28, 2022
Guest Article
Asa Waldstein
Q3 warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
Aug 5, 2022
Press Mention
Rachel Adams
Compliance responsibilities when using a contract manufacturer
Brands need to ensure regulatory responsibilities are accounted for at the start of a contract manufacturing partnership.
Aug 1, 2022
Interview
Mychealla Rice
The Future of CBD research, marketing, and regulation
In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD
Jul 8, 2022
Interview
Sheldon Baker
Limiting Marketing Risk for Hemp and CBD Products
Asa Waldstein, principal at Supplement Advisory Group, advises companies on how to navigate murky waters in today's marketplace.
Jun 1, 2022
Press Mention
Josh Long
NDI warning letters fuel criticism of FDA enforcement approach—again
Former FDA officials and lawyers who advise clients on FDA regulations weigh in on a recent batch of warning letters targeting new dietary ingredients marketed in supplements.
May 3, 2022
Guest Article
Asa Waldstein
Q2 FDA warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
May 3, 2022
Guest Article
Asa Waldstein
Compliance Essentials for Hemp-CBD Companies, Part 3 of 3: Marketing
May 2, 2022
Press Mention, Data Mention
Isabella Davis
Mental Wellbeing in Today's Digital Age
Presentation
Apr 19, 2022
Interview
EU’s new THC limits for hemp-based products will ‘level the playing field’ for food producers
Asa and other industry leaders interviewed
Apr 4, 2022
Press Mention
Lex Pelger, White Whale Creations
White Whale Creations Newsletter
Asa Waldstein's content is mentioned in this newsletter.
Apr 1, 2022
Guest Article
Asa Waldstein
Compliance Essentials for Hemp-CBD Companies Part 2 of 3
This edition talks about labeling essentials and best practices.
Mar 30, 2022
Relevant Article
Hemp Industry Daily
FDA, FTC slap CBD industry with seven warning letters related to COVID claims
Asa Waldstein quoted
Mar 17, 2022
Interview
Danielle Masterson
Stress: What can you claim on a product label?
Asa Waldstein and two top advertising attorneys share their tips and best practices for marketing stress supplements.
🔷Stress-free rules Ivan Wasserman, Amin Talati Wasserman, LLP
🔷Pooja's do's and don'ts Pooja Nair
🔷Asa's helpful hints Supplement Advisory Group
Mar 16, 2022
Press Mention
Julia Peterman
#NaturallyInformed Event Looks at Immune Health from All Angles
Asa Waldstein, Principal, Supplement Advisory Group, discussed the most recent info on FDA and FTC’s thinking regarding immune support in Communicating in-store and online—where are we now? “FDA is going back many years and citing multi-year-old social media posts in warning letters,” he shared. “One cited a social media post from 2014, and they treat those the same way as new posts. Hashtags are also claims. ‘Liking’ a post is a claim. Replying to or reposting a customer comment on social media, that’s a claim. All marketing is considered ‘labeling’.” That includes, he said, product reviews and testimonials; infographics; citing studies; blogs; and more.
Mar 1, 2022
Guest Article
Asa Waldstein
Q1 FDA warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
Feb 18, 2022
Guest Article
Asa Waldstein
Compliance Essentials for Hemp-CBD Companies Part 1 of 3
This edition talks about manufacturing essentials and reasons to think twice when building an overly robust Quality Management System (QMS).
Jan 28, 2022
Interview
Laura Drotleff
Researchers, hemp leaders caution cannabis producers against profiteering on early COVID research
Asa and other industry leaders interviewed
Jan 11, 2022
Guest Article
Let's Talk Hemp Media
Hemp Industry 2022 Opportunities Report
Asa writes the FDA and Hemp section of this prestigious annual paid publication.
Dec 22, 2021
Interview
Jean Lotus
Hemp Leaders Look Ahead to 2022
Asa and other industry leaders interviewed
Oct 13, 2021
Interview
Kate Robertson
Product Reviews & Marketing Claims
Asa and other industry leaders interviewed
